Free Trial

JanOne (JAN) Competitors

$2.73
-0.19 (-6.51%)
(As of 06/7/2024 08:52 PM ET)

JAN vs. BBBY, TCS, VTGN, ALLK, TLSA, LFVN, AFMD, VSTM, ASRT, and CNTB

Should you be buying JanOne stock or one of its competitors? The main competitors of JanOne include Bed Bath & Beyond (BBBY), The Container Store Group (TCS), Vistagen Therapeutics (VTGN), Allakos (ALLK), Tiziana Life Sciences (TLSA), LifeVantage (LFVN), Affimed (AFMD), Verastem (VSTM), Assertio (ASRT), and Connect Biopharma (CNTB).

JanOne vs.

Bed Bath & Beyond (NASDAQ:BBBY) and JanOne (NASDAQ:JAN) are both small-cap retail/wholesale companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, media sentiment, valuation, profitability, analyst recommendations, community ranking, institutional ownership, risk and dividends.

Bed Bath & Beyond has a beta of 1.49, suggesting that its share price is 49% more volatile than the S&P 500. Comparatively, JanOne has a beta of 2.1, suggesting that its share price is 110% more volatile than the S&P 500.

JanOne has a net margin of 0.00% compared to JanOne's net margin of -20.54%. JanOne's return on equity of 0.00% beat Bed Bath & Beyond's return on equity.

Company Net Margins Return on Equity Return on Assets
Bed Bath & Beyond-20.54% N/A -18.68%
JanOne N/A -359.71%-70.26%

Bed Bath & Beyond received 860 more outperform votes than JanOne when rated by MarketBeat users.

CompanyUnderperformOutperform
Bed Bath & BeyondOutperform Votes
860
52.06%
Underperform Votes
792
47.94%
JanOneN/AN/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bed Bath & Beyond
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
JanOne
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

In the previous week, JanOne had 1 more articles in the media than Bed Bath & Beyond. MarketBeat recorded 1 mentions for JanOne and 0 mentions for Bed Bath & Beyond. JanOne's average media sentiment score of 0.00 equaled Bed Bath & Beyond'saverage media sentiment score.

Company Overall Sentiment
Bed Bath & Beyond Neutral
JanOne Neutral

JanOne has lower revenue, but higher earnings than Bed Bath & Beyond.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bed Bath & Beyond$6.21B0.01-$559.62M-$15.20-0.01
JanOne$39.61M0.62-$7.81MN/AN/A

64.2% of Bed Bath & Beyond shares are held by institutional investors. Comparatively, 6.3% of JanOne shares are held by institutional investors. 1.7% of Bed Bath & Beyond shares are held by insiders. Comparatively, 3.0% of JanOne shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

JanOne beats Bed Bath & Beyond on 6 of the 11 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding JAN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

JAN vs. The Competition

MetricJanOnePharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$24.51M$6.95B$5.27B$8.17B
Dividend YieldN/A2.65%2.77%4.05%
P/E RatioN/A21.87137.3818.10
Price / Sales0.62270.452,448.4577.66
Price / CashN/A32.7535.7130.66
Price / Book-4.075.654.994.32
Net Income-$7.81M$147.15M$110.97M$216.21M
7 Day Performance-11.36%-2.06%-1.09%-1.44%
1 Month Performance-34.06%-2.59%-0.96%-0.97%
1 Year Performance141.59%-5.02%4.12%4.10%

JanOne Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BBBY
Bed Bath & Beyond
0.1326 of 5 stars
$0.08
flat
N/A-63.4%$33.78M$6.21B-0.0132,000Gap Up
TCS
The Container Store Group
3.191 of 5 stars
$0.72
+12.5%
$2.25
+212.6%
-78.5%$36.18M$847.78M-0.344,300Gap Down
VTGN
Vistagen Therapeutics
1.9329 of 5 stars
$3.90
-1.0%
$19.00
+387.2%
+77.9%$105.38M$1.11M0.0037Upcoming Earnings
News Coverage
ALLK
Allakos
4.1384 of 5 stars
$1.19
+2.6%
$1.83
+54.1%
-75.8%$105.36MN/A-0.49131
TLSA
Tiziana Life Sciences
0.6008 of 5 stars
$1.01
+1.0%
N/A+34.7%$104.12MN/A0.009Positive News
High Trading Volume
LFVN
LifeVantage
1.3472 of 5 stars
$7.95
flat
N/A+56.6%$100.97M$213.40M28.39248
AFMD
Affimed
3.8096 of 5 stars
$6.60
-1.2%
$45.00
+581.8%
-13.5%$100.52M$8.95M-0.79219Upcoming Earnings
VSTM
Verastem
2.3148 of 5 stars
$3.79
+3.0%
$25.69
+577.8%
-67.8%$96.00M$2.60M-0.8673
ASRT
Assertio
2.7812 of 5 stars
$1.00
+4.2%
$4.58
+358.5%
-83.2%$95.09M$152.07M-0.2553Positive News
CNTB
Connect Biopharma
1.3991 of 5 stars
$1.70
+3.7%
$6.50
+282.4%
+79.8%$93.67MN/A0.0081

Related Companies and Tools

This page (NASDAQ:JAN) was last updated on 6/10/2024 by MarketBeat.com Staff

From Our Partners